The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Cholesteryl ester storage disease: Review of the findings in 135 reported patients with an underdiagnosed disease
Open accessAbstract
Cholesteryl ester storage disease (CESD) is caused by deficient lysosomal acid lipase (LAL) activity, predominantly resulting in cholesteryl ester (CE) accumulation, particularly in the liver, spleen, and macrophages throughout the body. The disease is characterized by microvesicular steatosis leading to liver failure, accelerated atherosclerosis and premature demise. Although CESD is rare, it is likely that many patients are unrecognized or misdiagnosed. Here, the findings in 135 CESD patients described in the literature are reviewed. Diagnoses were based on liver biopsies, LAL deficiency and/or LAL gene (LIPA) mutations. Hepatomegaly was present in 99.3% of patients; 74% also had splenomegaly. When reported, most patients had elevated serum total cholesterol, LDL-cholesterol, triglycerides, and transaminases (AST, ALT, or both), while HDL-cholesterol was decreased. All 112 liver biopsied patients had the characteristic pathology, which is progressive, and includes microvesicular steatosis, which leads to fibrosis, micronodular cirrhosis, and ultimately to liver failure. Pathognomonic birefringent CE crystals or their remnant clefts were observed in hepatic cells. Extrahepatic manifestations included portal hypertension, esophageal varices, and accelerated atherosclerosis. Liver failure in 17 reported patients resulted in liver transplantation and/or death. Genotyping identified 31 LIPA mutations in 55 patients; 61% of mutations were the common exon 8 splice-junction mutation (E8SJM(-1G>A)), for which 18 patients were homozygous. Genotype/phenotype correlations were limited; however, E8SJM(-1G>A) homozygotes typically had early-onset, slowly progressive disease. Supportive treatment included cholestyramine, statins, and, ultimately, liver transplantation. Recombinant LAL replacement was shown to be effective in animal models, and recently, a phase I/II clinical trial demonstrated its safety and indicated its potential metabolic efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
The Metabolic Basis of Inherited Disease.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-5-839_2 · Cited by 1,318
The Human Gene Mutation Database: 2008 update
Stenson, P. D., Mort, M., Ball, E. V., Howells, K., Phillips, A. D., Thomas, N. S., & Cooper, D. N. (2009) · Genome Medicine · doi:10.1186/gm13 · Cited by 873
Begriche, K., Massart, J., Robin, M.-A., Borgne-Sanchez, A., & Fromenty, B. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.006 · Cited by 555
Goldstein, J., Dana, S., Faust, Jr., Beaudet, A., & Brown, M. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40786-2 · Cited by 391
Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease
Tandra, S., Yeh, M. M., Brunt, E. M., Vuppalanchi, R., Cummings, O. W., Ünalp-Arida, A., Wilson, L. A., & Chalasani, N. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.021 · Cited by 326
Fromenty, B., & Pessayre, D. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80496-5 · Cited by 267
PRIMARY FAMILIAL XANTHOMATOSIS WITH INVOLVEMENT AND CALCIFICATION OF THE ADRENALS
Wolman, M., Sterk, V. V., Gatt, S., & Frenkel, M. (1961) · Pediatrics · doi:10.1542/peds.28.5.742 · Cited by 209
Ginsberg, H. N., Le, N. A., Short, M. P., Ramakrishnan, R., & Desnick, R. J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113259 · Cited by 202
Self-citationHamilton, J., Jones, I., Srivastava, R., & Galloway, P. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.03.019 · Cited by 191
Roussel, A., Canaan, S., Egloff, M.-P., Rivière, M., Dupuis, L., Verger, R., & Cambillau, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16995 · Cited by 170
Aslanidis, C., Ries, S., Fehringer, P., Büchler, C., Klima, H., & Schmitz, G. (1996) · Genomics · doi:10.1006/geno.1996.0162 · Cited by 162
Du, H. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.9.1347 · Cited by 153
Anderson, R. A., & Sando, G. N. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54597-x · Cited by 150
Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein.
Brown, M. S., Dana, S. E., & Goldstein, J. L. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.2925 · Cited by 146
Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease
Anderson, R. A., Byrum, R. S., Coates, P. M., & Sando, G. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2718 · Cited by 142
Trost, L. C., & Lemasters, J. J. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20745-5 · Cited by 131
Enzyme deficiency in cholesteryl ester storage disease
Sloan, H. R., & Fredrickson, D. S. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106997 · Cited by 127
GENERALIZED XANTHOMATOSIS WITH CALCIFIED ADRENALS
ABRAMOV, A. (1956) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1956.02060020284010 · Cited by 125
Treem, W. R., Witzleben, C. L., Piccoli, D. A., Stanley, C. A., Hale, D. E., Coates, P. M., & Watkins, J. B. (1986) · Hepatology · doi:10.1002/hep.1840060608 · Cited by 108
Klima, H., Ullrich, K., Aslanidis, C., Fehringer, P., Lackner, K. J., & Schmitz, G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116888 · Cited by 101
Bowden, K., Bilbey, N., Bilawchuk, L. M., Boadu, E., Sidhu, R., Ory, D. S., Du, H., Chan, T., & Francis, G. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274381 · Cited by 101
Enzyme therapy for lysosomal acid lipase deficiency in the mouse
Du, H. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.16.1639 · Cited by 95
Cholesterol ester storage disease: Clinical, biochemical, and pathological studies
Beaudet, A. L., Ferry, G. D., Nichols, B. L., & Rosenberg, H. S. (1977) · The Journal of Pediatrics · doi:10.1016/s0022-3476(77)80557-x · Cited by 94
Hůlková, H., & Elleder, M. (2012) · Histopathology · doi:10.1111/j.1365-2559.2011.04164.x · Cited by 93
Deficient Activity of Hepatic Acid Lipase in Cholesterol Ester Storage Disease
Burke, J. A., & Schubert, W. K. (1972) · Science · doi:10.1126/science.176.4032.309 · Cited by 87
Anderson, R. A., Bryson, G. M., & Parks, J. S. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2904 · Cited by 86
Elleder, M., Chlumská, A., Hyánek, J., Poupětová, H., Ledvinová, J., Maas, S., & Lohse, P. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80407-9 · Cited by 84
Microvesicular Steatosis of the Liver
Hautekèete, M., Degott, C., & Benhamou, J. P. (1990) · Acta Clinica Belgica · doi:10.1080/17843286.1990.11718105 · Cited by 83
Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene
Pisciotta, L., Fresa, R., Bellocchio, A., Pino, E., Guido, V., Cantàfora, A., Rocco, M. D., Calandra, S., & Bertolini, S. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.02.007 · Cited by 79
Pagani, F., Pariyarath, R., Garcia, R. C., Stuani, C., Burlina, A., Ruotolo, G., Rabusin, M., & Baralle, F. E. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32518-9 · Cited by 72
The Role of Mannosylated Enzyme and the Mannose Receptor in Enzyme Replacement Therapy
Du, H., Levine, M., Ganesa, C., Witte, D. P., Cole, E. S., & Grabowski, G. A. (2005) · The American Journal of Human Genetics · doi:10.1086/498652 · Cited by 67
Hepatic cholesterol ester storage disease, a familial disorder
Schiff, L., Schubert, W. K., McAdams, A. J., Spiegel, E. L., & OʼDonnell, J. F. (1968) · The American Journal of Medicine · doi:10.1016/0002-9343(68)90054-5 · Cited by 62
Du, H., Heur, M., Witte, D. P., Ameis, D., & Grabowski, G. A. (2002) · Human Gene Therapy · doi:10.1089/104303402760128586 · Cited by 61
Dahl, S. V., HARZER, K., Rolfs, A., Albrecht, B., Niederau, C., Vogt, C., van Weely, S., Aerts, J. M. F. G., Müller, G., & Häussinger, D. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80356-0 · Cited by 60
Lohse, P., Maas, S., Lohse, P., Elleder, M., Kirk, J. M., BESLEY, G. T. N., & Seidel, D. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32070-8 · Cited by 59
Tadiboyina, V. T., Liu, D. M., Miskie, B. A., Wang, J., & Hegele, R. A. (2005) · Lipids in Health and Disease · doi:10.1186/1476-511x-4-26 · Cited by 59
Acid lipase in cultured fibroblasts: cholesterol ester storage disease.
Beaudet, A. L., Mh, L., Gd, F., & Bl, N. (1974) · PubMed · Cited by 58
Jm, H., Demosky, S. J., Pescovitz, O. H., & Brewer, H. B. (1984) · Europe PMC (PubMed Central) · Cited by 56
Ameis, D., Brockmann, G., Knoblich, R., Merkel, M., Ostlund, R. E., Yang, J. W., Coates, P. M., Cortner, J. A., Feinman, S. V., & Greten, H. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39900-4 · Cited by 55
Molecular and Enzymatic Analyses of Lysosomal Acid Lipase in Cholesteryl Ester Storage Disease
Du, H., Sheriff, S., Bezerra, J. A., Leonova, T., & Grabowski, G. A. (1998) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1998.2707 · Cited by 52
Deficiency of Acid Esterase Activity in Wolman's Disease
Young, E. P., & PATRICK, A. D. (1970) · Archives of Disease in Childhood · doi:10.1136/adc.45.243.664 · Cited by 50
Pagani, F. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.10.1611 · Cited by 49
Newly Recognized Disorders of Cholesterol Metabolism.
Fredrickson, D. S. (1963) · Annals of Internal Medicine · doi:10.7326/0003-4819-58-4-718_1 · Cited by 48
Seedorf, U., Wiebusch, H., Muntoni, S., CHRISTENSEN, N. C., Skovby, F., Nickel, V., Roskos, M., Funke, H., Ose, L., & Assmann, G. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.6.773 · Cited by 45
Wolman Disease (LIPA p.G87V) Genotype Frequency in People of Iranian-Jewish Ancestry
Valles‐Ayoub, Y., Esfandiarifard, S., No, D. J., Sinai, P., Khokher, Z., Kohan, M., Kahen, T., & Darvish, D. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0203 · Cited by 45
Muntoni, S., Wiebusch, H., Funke, H., Ros, E., Seedorf, U., & Assmann, G. (1995) · Human Genetics · doi:10.1007/bf00223858 · Cited by 43
Structural bases of Wolman disease and cholesteryl ester storage disease
Saito, S., Ohno, K., Suzuki, T., & Sakuraba, H. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.11.004 · Cited by 42
Cholesteryl ester storage disease: complex molecular effects of chronic lovastatin therapy.
Levy, R. A., Ostlund, R., Schonfeld, G., Wong, P., & Semenkovich, C. F. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41416-6 · Cited by 41
A new mutation in the gene for lysosomal acid lipase leads to Wolman disease in an African kindred.
Ries, S. R., Aslanidis, C., Fehringer, P., Carel, J., Gendrel, D., & Schmitz, G. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39119-7 · Cited by 36
Heterozygosity for lysosomal acid lipase E8SJM mutation and serum lipid concentrations
Muntoni, S., Wiebusch, H., Jansen-Rust, M., Rust, S., Schulte, H., Berger, K., Pisciotta, L., Bertolini, S., Funke, H., Seedorf, U., et al. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.05.009 · Cited by 35
Lysosomal Acid Lipase Deficiency
Hoffman, E., Barr, M. L., Giovanni, M. A., & Murray, M. F. (2016) · Europe PMC (PubMed Central) · Cited by 28
Cholesteryl ester storage disease: Pathologic changes in an affected fetus
Desai, P. K., Astrin, K. H., Thung, S. N., Gordon, R. E., Short, M. P., Coates, P. M., Desnick, R. J., & Reynolds, J. F. (1987) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320260324 · Cited by 26
Self-citationAsymptomatic Cholesteryl Ester Storage Disease in an Adult Controlled with Simvastatin
Iverson, S. A., Cairns, S. R., Ward, C., & Fensom, A. H. (1997) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329703400418 · Cited by 26
Sundaravalli, N., Bhaskar Raju, B., Prema, A., Pushpa, Nedunchelian, N., Mv, S., & Sudarsanam, D. (1986) · PubMed · Cited by 26
Cholesteryl ester hydrolase activity in human symptomatic atherosclerosis
Yatsu, F. M., Hagemenas, F. C., Manaugh, L. C., & Galambos, T. (1980) · Lipids · doi:10.1007/bf02534317 · Cited by 25
Redonnet‐Vernhet, I., Chatelut, M., Basile, J., Salvayre, R., & Levade, T. (1997) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1997.2626 · Cited by 22
Treatment of Cholesteryl Ester Storage Disease with Combined Cholestyramine and Lovastatin
McCoy, E. E., & Yokoyama, S. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb43768.x · Cited by 19
Maslen, C. L., Babcock, D., & Illingworth, D. R. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf02436008 · Cited by 18
A novel lysosomal acid lipase gene mutation in a patient with cholesteryl ester storage disease.
Redonnet‐Vernhet, I., Chatelut, M., Salvayre, R., & Levade, T. (1998) · PubMed · Cited by 18
Cholesteryl ester storage disease: a patient with massive splenomegaly and splenic abscess.
Edelstein, R. A., Filling‐Katz, M. R., Pentchev, P. G., Gál, A., Chandra, R., Shawker, T. H., Guzzetta, P. C., Comly, M. E., Kaneski, C., & Brady, R. O. (1988) · PubMed · Cited by 18
Gallbladder Dysfunction in Cholesterol Ester Storage Disease
Haller, W., Sharif, K., Millar, A. J., Brown, R. M., & McKiernan, P. J. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31819f659b · Cited by 15
Saibara, T., Himeno, H., Ueda, H., Onishi, S., Yamamoto, Y., Enzan, H., Hara, H., Takehara, Y., & Utsumi, K. (1994) · PubMed · Cited by 12
Muscle involvement in cholesterol ester storage disease
Navarro, C., Fernández, J. M., Domı́nguez, C., Aznar, A. O., Sancho, S., & García, J. (1992) · Neurology · doi:10.1212/wnl.42.5.1120 · Cited by 4
(1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1098-1004(1998)12:1 · Cited by 1
Congenital cholesteryl ester storage disease: What are the implications in pregnancy?
Gidiri, M. F., Masson, E. A., Kilpatrick, E. S., & Lindow, S. W. (2008) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2008.10.002 · Cited by 1
Cited by
Nonalcoholic fatty liver disease
Brunt, E. M., Wong, V. W.-S., Nobili, V., Day, C. P., Sookoian, S., Maher, J. J., Bugianesi, E., Sirlin, C. B., Neuschwander-Tetri, B. A., & Rinella, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.80 · Cited by 818
Lipolysis: cellular mechanisms for lipid mobilization from fat stores
Grabner, G. F., Xie, H., Schweiger, M., & Zechner, R. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00493-6 · Cited by 765
ATUALIZAÇÃO DA DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ATEROSCLEROSE - 2017
Faludi, A., Izar, M., Saraiva, J., Chacra, A., Bianco, H., Afiune Neto, A., Bertolami, A., Pereira, A., Lottenberg, A., Sposito, A., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170121 · Cited by 633
Cytosolic lipolysis and lipophagy: two sides of the same coin
Zechner, R., Madeo, F., & Kratky, D. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.76 · Cited by 550
Lipid droplet size directs lipolysis and lipophagy catabolism in hepatocytes
Schott, M. B., Weller, S. G., Schulze, R. J., Krueger, E. W., Drizyte-Miller, K., Casey, C. A., & McNiven, M. A. (2019) · Journal of Cell Biology · doi:10.1083/jcb.201803153 · Cited by 348
Metadata
- Authors
- Bernstein, D. L., Hülkova, H., Bialer, M. G., & Desnick, R. J.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 58
- Issue
- 6
- Pages
- 1230-1243
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W1995292072
- Cited by
- 379
- References
- 68
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.